Developing Rapid, Integrated Biodefense Response Capability: "The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded Northrop Grumman a contract to develop a new bio-defense system capable of rapidly determining if a person has been exposed to a biological threat. The award was made under BARDA's Innovative Platform Technologies program.
BioCHAMP-RSP (Confirmation of Harmful Agents by MassTag PCR - Rapid Screening Platform) will provide an innovative system capability to simultaneously identify over 30 pathogens, bacterial and viral, in human samples.
Under the one-year $9.6 million contract, Northrop Grumman will design, assemble and test two BioCHAMP-RSP prototypes. The system will allow first responders the ability to rapidly provide triage to people who were exposed to biological threats and appropriately allocate medical resources.
"
